Literature DB >> 8122516

Structure and molecular regulation of bone matrix proteins.

P G Robey1, N S Fedarko, T E Hefferan, P Bianco, U K Vetter, W Grzesik, A Friedenstein, G Van der Pluijm, K P Mintz, M F Young.   

Abstract

The organic matrix of bone contains several protein families, including collagens, proteoglycans, and glycoproteins, all of which may be extensively modified by posttranslational events, such as phosphorylation and sulfation. Many of the glycoproteins contain Arg-Gly-Asp (RGD), the integrin-binding sequence, within their structure, whereas other constituent proteins contain gamma-carboxyglutamic acid. The deposition of bone matrix by cells in the osteoblastic lineage is regulated by extrinsic factors, such as systemic and local growth factors and physical forces, and factors that are intrinsic to the cell, such as position in the cell cycle, maturational stage, and developmental age of the donor. Recent studies of several bone matrix gene promoters have identified cis- and trans-acting elements that are responsible for gene activity, although the precise sequence of regulatory events is not known. Development of in vitro assays, coupled with studies of the appearance of these proteins during development in vivo, provides insight into the functions of these proteins during the various stages of bone metabolism. Potential roles for these proteins include proliferation and maturation of stem cells, formation of matrix scaffolding elaborated by bone-forming cells, modeling, and remodeling. Changes in the functional properties of the extracellular matrix may be involved in a variety of disease processes, including osteoporosis and oral bone loss.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8122516     DOI: 10.1002/jbmr.5650081310

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  20 in total

1.  [In vitro trials with single and co-cultures of osteoblasts and endothelial cells : evaluation of new biomaterials for bone reconstruction and regeneration].

Authors:  R E Unger; S Halstenberg; H Günther; A Sartoris; C Brochhausen; C J Kirkpatrick
Journal:  Orthopade       Date:  2009-11       Impact factor: 1.087

Review 2.  Nanomedicine for safe healing of bone trauma: Opportunities and challenges.

Authors:  Shahed Behzadi; Gaurav A Luther; Mitchel B Harris; Omid C Farokhzad; Morteza Mahmoudi
Journal:  Biomaterials       Date:  2017-09-04       Impact factor: 12.479

3.  Age-related changes in effects of insulin-like growth factor I on human osteoblast-like cells.

Authors:  P Y D'avis; C R Frazier; J R Shapiro; N S Fedarko
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

4.  Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves.

Authors:  S S Srivatsa; P J Harrity; P B Maercklein; L Kleppe; J Veinot; W D Edwards; C M Johnson; L A Fitzpatrick
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

5.  Glucocorticoids induce a near-total suppression of hyaluronan synthase mRNA in dermal fibroblasts and in osteoblasts: a molecular mechanism contributing to organ atrophy.

Authors:  W Zhang; C E Watson; C Liu; K J Williams; V P Werth
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

Review 6.  Stem cells: update and impact on craniofacial surgery.

Authors:  Benjamin Levi; Jason P Glotzbach; Victor W Wong; Emily R Nelson; Jeong Hyun; Derrick C Wan; Geoffrey C Gurtner; Michael T Longaker
Journal:  J Craniofac Surg       Date:  2012-01       Impact factor: 1.046

7.  Osteonectin-derived peptide increases the modulus of a bone-mimetic nanocomposite.

Authors:  Alireza S Sarvestani; Xuezhong He; Esmaiel Jabbari
Journal:  Eur Biophys J       Date:  2007-07-04       Impact factor: 1.733

Review 8.  Design, materials, and mechanobiology of biodegradable scaffolds for bone tissue engineering.

Authors:  Marco A Velasco; Carlos A Narváez-Tovar; Diego A Garzón-Alvarado
Journal:  Biomed Res Int       Date:  2015-03-26       Impact factor: 3.411

9.  Enhanced in vivo osteogenesis by nanocarrier-fused bone morphogenetic protein-4.

Authors:  Yasuyuki Shiozaki; Takashi Kitajima; Tetsuro Mazaki; Aki Yoshida; Masato Tanaka; Akihiro Umezawa; Mariko Nakamura; Yasuhiro Yoshida; Yoshihiro Ito; Toshifumi Ozaki; Akihiro Matsukawa
Journal:  Int J Nanomedicine       Date:  2013-04-09

Review 10.  Immunohistochemical and biochemical assay of versican in human sound predentine/dentine matrix.

Authors:  A Ruggeri; G Orsini; A Mazzoni; F Nato; V Papa; M Piccirilli; A Putignano; G Mazzotti; E De Stefano Dorigo; L Breschi
Journal:  Eur J Histochem       Date:  2009-09-30       Impact factor: 3.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.